| |
| |
|
| Insider
Information: |
Young Kevin |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
55,612 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,660,695 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,612 |
|
|
| Total
Value |
$1,660,695 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Operating Officer |
2018-02-21 |
25,612 |
2006-02-02 |
0 |
Premium* |
|
|
Cortexyme, Inc. |
CRTX |
Director |
2019-05-13 |
30,000 |
2019-05-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-03-12 |
4 |
D |
$44.04 |
$261,950 |
D/D |
(5,948) |
19,868 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-04-03 |
4 |
OE |
$16.01 |
$513,600 |
D/D |
30,000 |
49,868 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-04-03 |
4 |
S |
$46.83 |
$1,422,321 |
D/D |
(30,000) |
19,868 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-07-09 |
4 |
S |
$44.63 |
$1,338,990 |
D/D |
(30,000) |
20,347 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-07-09 |
4 |
OE |
$16.01 |
$513,600 |
D/D |
30,000 |
50,347 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-10-05 |
4 |
S |
$44.70 |
$1,341,105 |
D/D |
(30,000) |
20,347 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-10-05 |
4 |
OE |
$16.01 |
$513,600 |
D/D |
30,000 |
50,347 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-12-01 |
4 |
OE |
$16.01 |
$1,253,887 |
D/D |
75,000 |
95,347 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-12-01 |
4 |
S |
$45.80 |
$3,435,143 |
D/D |
(75,000) |
20,347 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2010-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
46,347 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2010-03-08 |
4 |
D |
$47.01 |
$521,012 |
D/D |
(11,083) |
35,264 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2010-08-24 |
4 |
OE |
$17.68 |
$176,750 |
D/D |
10,000 |
45,841 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2011-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
19,375 |
65,216 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2011-03-15 |
4 |
D |
$39.79 |
$322,896 |
D/D |
(8,115) |
57,101 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2011-03-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
23,250 |
69,091 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2011-03-15 |
4/A |
D |
$39.79 |
$394,876 |
D/D |
(9,924) |
59,167 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2012-03-12 |
4 |
D |
$46.16 |
$472,217 |
D/D |
(10,230) |
72,769 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2012-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
23,100 |
82,999 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2012-06-29 |
4 |
A |
$29.02 |
$21,271 |
D/D |
733 |
73,502 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2012-11-16 |
4 |
OE |
$16.01 |
$1,770,286 |
D/D |
100,746 |
174,248 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2012-11-16 |
4 |
S |
$74.66 |
$7,521,958 |
D/D |
(100,746) |
73,502 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2012-11-19 |
4 |
OE |
$29.01 |
$10,441,800 |
D/D |
360,000 |
433,502 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2012-11-19 |
4 |
S |
$74.31 |
$26,751,312 |
D/D |
(360,000) |
73,502 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2013-01-30 |
5 |
A |
$0.00 |
$0 |
D/D |
21,332 |
183,172 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2013-03-06 |
4 |
D |
$45.40 |
$686,993 |
D/D |
(15,132) |
161,840 |
0 |
- |
|
85 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
